Skip to main content
. 2021 Feb 11;16(2):e0246525. doi: 10.1371/journal.pone.0246525

Table 4. Healthcare access, vaccinations, among cisgender, trans, and non-binary participants.

Overall Cisgender Trans Non-Binary
Has regular HCP n % n % n % OR AOR n % OR AOR
No 851 24.1% 752 24.4% 59 19.9% Ref Ref 40 26.7% Ref Ref
Yes 2524 71.6% 2212 71.7% 226 76.4% 1.30 (0.97–1.77) 1.82 (1.30–2.57) 107 71.3% 0.91 (0.63–1.33) 1.53 (1.00–2.38)
Ever vaccinated for HBV
No 435 12.3% 367 11.9% 40 13.5% Ref Ref 21 14.0% Ref Ref
Unsure 546 15.5% 459 14.9% 66 22.3% 1.32 (0.87–2.01) 1.23 (0.77–1.99) 34 22.7% 1.29 (0.74–2.30) 1.18 (0.63–2.24)
Yes 2336 66.3% 2092 67.9% 173 58.4% 0.76 (0.53–1.10) 1.15 (0.77–1.76) 88 58.7% 0.74 (0.46–1.23) 1.09 (0.64–1.94)
Ever vaccinated for HPV
No 1361 38.6% 1221 39.6% 86 29.1% Ref Ref 41 27.3% Ref Ref
Unsure 709 20.1% 605 19.6% 75 25.3% 1.76 (1.27–2.43) 1.21 (0.83–1.74) 38 25.3% 1.87 (1.19–2.94) 1.29 (0.77–2.14)
Yes 1083 30.7% 942 30.6% 113 38.2% 1.70 (1.27–2.29) 1.51 (1.08–2.12) 54 36.0% 1.71 (1.13–2.60) 1.47 (0.92–2.36)
Asked and Denied (ref: no)
An HIV test 124 3.5% 103 3.3% 17 5.7% 1.75 (1.00–2.89) 1.29 (0.68–2.30) 9 6.0% 1.85 (0.85–3.55) 1.40 (0.60–2.94)
PEP 42 1.2% 32 1.0% 8 2.7% 2.61 (1.11–5.46) 2.29 (0.87–5.42) 3 2.0% 1.95 (0.46–5.52) 1.69 (0.35–5.77)
PrEP 80 2.3% 72 2.3% 7 2.4% 1.00 (0.41–2.04) 0.99 (0.37–2.25) 3 2.0% 0.85 (0.21–2.32) 0.87 (0.19–2.67)
HPV vaccination 62 1.8% 49 1.6% 12 4.1% 2.58 (1.30–4.76) 2.78 (1.25–5.79) 5 3.3% 2.14 (0.73–4.97) 1.87 (0.56–5.19)
Hormone therapy 57 1.6% 9 0.3% 46 15.5% 63.13 (32.00–139.36) 31.60 (14.43–75.96) 20 13.3% 53.26 (24.41–125.38) 24.82 (9.19–72.61)
Gender affirming surgery 42 1.2% 5 0.2% 36 12.2% 84.95 (36.15–249.04) 50.65 (19.10–161.85) 14 9.3% 63.92 (24.04–200.38) 36.71 (10.69–144.38)
None of the above 2891 82.0% 2595 84.2% 192 64.9% 0.20 (0.15–0.26) 0.24 (0.17–0.34) 102 68.0% 0.24 (0.16–0.37) 0.28 (0.17–0.46)